Header cover image

U.S. Healthtech Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies67
  • 7D3.2%
  • 3M-3.6%
  • 1Y-19.3%
  • YTD-8.8%

The Healthtech industry is up 3.2% in the last week, with Veeva Systems up 3.4%. However, the industry is down 19% over the past year. As for the next few years, earnings are expected to grow by 29% per annum.

Industry Valuation and Performance

Has the U.S. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024US$58.7bUS$13.7b-US$1,860,658,542.0051.6x-31.5x4.3x
Sun, 23 Jun 2024US$57.2bUS$13.7b-US$1,889,788,216.0047.3x-30.3x4.2x
Tue, 21 May 2024US$59.1bUS$12.8b-US$1,973,252,856.0046.9x-29.9x4.6x
Thu, 18 Apr 2024US$57.3bUS$12.7b-US$1,620,331,315.0048.2x-35.4x4.5x
Sat, 16 Mar 2024US$64.8bUS$14.3b-US$1,457,126,316.0048.8x-44.5x4.5x
Mon, 12 Feb 2024US$63.6bUS$13.8b-US$5,675,716,752.0061.6x-11.2x4.6x
Wed, 10 Jan 2024US$71.5bUS$18.3b-US$5,780,492,665.0054.8x-12.4x3.9x
Fri, 08 Dec 2023US$66.7bUS$18.3b-US$5,772,419,665.0052.6x-11.6x3.6x
Sun, 05 Nov 2023US$68.0bUS$18.3b-US$5,826,818,376.0052x-11.7x3.7x
Tue, 03 Oct 2023US$70.0bUS$18.0b-US$5,559,240,965.0052.1x-12.6x3.9x
Thu, 31 Aug 2023US$71.1bUS$17.9b-US$5,546,705,389.0050.9x-12.8x4x
Sat, 29 Jul 2023US$77.7bUS$17.8b-US$5,538,206,318.0062.2x-14x4.4x
Mon, 26 Jun 2023US$75.2bUS$17.7b-US$8,580,509,261.0062x-8.8x4.2x
Wed, 24 May 2023US$69.3bUS$17.7b-US$8,622,664,320.0058.3x-8x3.9x
Fri, 21 Apr 2023US$74.8bUS$17.4b-US$14,978,330,855.0059.2x-5x4.3x
Sun, 19 Mar 2023US$71.2bUS$17.7b-US$15,404,092,855.0052.6x-4.6x4x
Tue, 14 Feb 2023US$72.9bUS$17.5b-US$10,822,839,563.0053.7x-6.7x4.2x
Thu, 12 Jan 2023US$69.9bUS$17.5b-US$10,803,491,310.0045.3x-6.5x4x
Sat, 10 Dec 2022US$72.0bUS$17.5b-US$10,606,433,310.0049.8x-6.8x4.1x
Mon, 07 Nov 2022US$66.6bUS$17.4b-US$10,579,915,342.0032.9x-6.3x3.8x
Wed, 05 Oct 2022US$73.7bUS$17.1b-US$10,593,627,342.0032.5x-7x4.3x
Fri, 02 Sep 2022US$75.5bUS$17.0b-US$10,549,847,342.0033.5x-7.2x4.4x
Sun, 31 Jul 2022US$95.6bUS$17.5b-US$10,943,133,542.0046.9x-8.7x5.5x
Tue, 28 Jun 2022US$121.9bUS$23.2b-US$7,415,282,621.0053x-16.4x5.2x
Thu, 26 May 2022US$111.9bUS$23.1b-US$7,379,417,621.0048.3x-15.2x4.8x
Sat, 23 Apr 2022US$128.3bUS$23.4b-US$981,384,493.0066.4x-130.7x5.5x
Mon, 21 Mar 2022US$141.1bUS$23.9b-US$869,737,328.0082.4x-162.2x5.9x
Wed, 16 Feb 2022US$157.6bUS$23.9b-US$1,706,183,715.0091.7x-92.4x6.6x
Fri, 14 Jan 2022US$157.5bUS$23.7b-US$1,729,195,532.0091.6x-91.1x6.6x
Sun, 12 Dec 2021US$168.5bUS$23.1b-US$1,291,880,240.0099x-130.4x7.3x
Tue, 09 Nov 2021US$206.1bUS$22.8b-US$1,325,896,292.00111.8x-155.4x9x
Thu, 07 Oct 2021US$189.2bUS$22.1b-US$1,254,921,150.00100.5x-150.8x8.6x
Sat, 04 Sep 2021US$196.9bUS$21.9b-US$1,229,889,348.31106.3x-160.1x9x
Mon, 02 Aug 2021US$187.5bUS$21.9b-US$1,229,889,348.3196.2x-152.4x8.6x
Price to Earnings Ratio

-152.4x


Total Market Cap: US$187.5bTotal Earnings: -US$1,229,889,348.31Total Revenue: US$21.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthtech Industry Price to Earnings3Y Average -46.7x202220232024
Current Industry PE
  • Investors are pessimistic on the American Healthcare Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.0x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have deteriorated over the last three years.
  • Revenues have also declined 15% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-2.42%
Healthcare1.13%
Healthtech3.19%
Healthtech3.19%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VEEV Veeva SystemsUS$186.553.4%
+US$989.3m
-6.1%PE54.3x
GDRX GoodRx HoldingsUS$8.748.4%
+US$255.1m
31.6%PS4.3x
EVH Evolent HealthUS$22.1910.2%
+US$236.2m
-25.2%PS1.2x
WAY Waystar HoldingUS$23.123.2%
+US$120.5m
n/aPS4.7x
PHR PhreesiaUS$24.427.8%
+US$101.6m
-18.6%PS3.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ONMD

US$0.83

OneMedNet

7D

-16.5%

1Y

-92.5%

HCAT

US$7.79

Health Catalyst

7D

12.2%

1Y

-40.6%

HSTM

US$28.77

HealthStream

7D

-5.2%

1Y

30.0%

SOPH

US$4.63

SOPHiA GENETICS

7D

-0.6%

1Y

21.8%

SLP

US$39.49

Simulations Plus

7D

-4.5%

1Y

-20.7%

AUGX

US$2.27

Augmedix

7D

147.7%

1Y

-42.8%

WAY

US$23.12

Waystar Holding

7D

3.2%

1Y

n/a

GDRX

US$8.74

GoodRx Holdings

7D

8.4%

1Y

31.6%

EVH

US$22.19

Evolent Health

7D

10.2%

1Y

-25.2%

MEDS

US$11.63

TRxADE HEALTH

7D

-48.1%

1Y

54.2%